1 active not recruiting, 1 completed, 1 recruiting, 1 unknown. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Recruiting 1 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
Follow ISS Stage III Plasma Cell Myeloma: new trials by email Literature Review of ISS Stage III Plasma Cell Myeloma trials Research Report on ISS Stage III Plasma Cell Myeloma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial Bone Marrow Aspiration and Biopsy, Carfilzomib, Computed Tomography - ISS Stage III Plasma Cell Myeloma, Multiple Myeloma | Phase 2 | Active not recruiting | Mayo Clinic | 17 | 2022-09-22 | 2026-05-13 |
| Pembrolizumab and Radiation Therapy in Patients With Relapsed or Refractory Multiple Myeloma Pembrolizumab, Radiation Therapy - ISS Stage I Plasma Cell Myeloma, ISS Stage II Plasma Cell Myeloma | Phase 1 / Phase 2 | Completed | Emory University | 25 | 2018-05-29 | 2024-09-04 |
| Personalized NK Cell Therapy in CBT Allogeneic Natural Killer Cell Line NK-92, Anti-Thymocyte Globulin, Busulfan - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 100 | 2016-05-19 | 2026-07-30 |
| NK Cells in Cord Blood Transplantation Allogeneic Hematopoietic Stem Cell Transplantation, Cyclophosphamide, Fludarabine Phosphate - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia | Phase 1 | Unknown | M.D. Anderson Cancer Center | 13 | 2013-05-03 | 2020-02-11 |
Hodgkin Disease (2) · Leukemia, Biphenotypic, Acute (2) · Leukemia, Myeloid, Accelerated Phase (2) · Leukemia, Myeloid, Acute (2) · Leukemia, Myeloid, Chronic-Phase (2) · Lymphoma, Non-Hodgkin (2) · Multiple Myeloma (2) · Myelodysplastic Syndromes (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Anemia, Refractory, with Excess of Blasts (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myelomonocytic, Chronic (1) · Myelodysplastic-Myeloproliferative Diseases (1)
Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Immune System Diseases (4) · Immunoproliferative Disorders (4) · Lymphoproliferative Disorders (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Blood Protein Disorders (2) · Bone Marrow Diseases (2) · Cardiovascular Diseases (2) · Chronic Disease (2) · Disease Attributes (2) · Hemorrhagic Disorders (2) · Hemostatic Disorders (2) · Leukemia (2)
CT-P10 (2) · Cord Blood Stem Cell Transplantation (2) · Cyclophosphamide (2) · Lenalidomide (2) · Melphalan (2) · Rituximab (2) · Whole-Body Irradiation (2) · fludarabine phosphate (2) · Antilymphocyte Serum (1) · Biopsy (1) · Busulfan (1) · Calcium Dobesilate (1) · Clofarabine (1) · Dexamethasone (1) · Magnetic Resonance Spectroscopy (1)
M.D. Anderson Cancer Center (2) · Emory University (1) · Mayo Clinic (1)
United States (4)
Chitra Hosing (1) · Mohammad K. Khan, MD, PhD (1) · Shaji K. Kumar, MD (1) · Warren Fingrut, MD (1)
P30CA016672 (1), P30CA138292 (1), P50CA186781 (1), R01CA211044 (1)